{"entities":{"Q9870":{"pageid":14031,"ns":120,"title":"Item:Q9870","lastrevid":205790,"modified":"2020-05-21T15:46:52Z","type":"item","id":"Q9870","labels":{"en":{"language":"en","value":"Catenacci DV, et al. J. Clin. Oncol. (2015) cited as Ref 607 in DOI: 10.1038/s41392-020-0110-5"}},"descriptions":{"en":{"language":"en","value":"Cited in: \"Targeting cancer stem cell pathways for cancer therapy\" in Signal Transduct Target Ther; 2020 ; 5 8"}},"aliases":[],"claims":{"P17":[{"mainsnak":{"snaktype":"value","property":"P17","datavalue":{"value":{"entity-type":"item","numeric-id":7916,"id":"Q7916"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q9870$41E16DB8-4427-4D70-AC27-DFF9DAA82C4D","rank":"normal"}],"P94":[{"mainsnak":{"snaktype":"value","property":"P94","datavalue":{"value":{"entity-type":"item","numeric-id":8449,"id":"Q8449"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q9870$37C004A3-7B5D-4344-B705-8DE218251F06","rank":"normal"}],"P149":[{"mainsnak":{"snaktype":"value","property":"P149","datavalue":{"value":"Catenacci DV","type":"string"},"datatype":"string"},"type":"statement","id":"Q9870$A6ECD012-A245-4D51-B913-BFF2704D47CE","rank":"normal"}],"P138":[{"mainsnak":{"snaktype":"value","property":"P138","datavalue":{"value":"10.1200/JCO.2015.62.8719","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q9870$457F74BD-C7BD-41DB-A583-FE3F2F3904FB","rank":"normal"}],"P140":[{"mainsnak":{"snaktype":"value","property":"P140","datavalue":{"value":"26527777","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q9870$C9BAC13B-D75F-4604-9419-FD8798C5EF9A","rank":"normal"}],"P100":[{"mainsnak":{"snaktype":"value","property":"P100","datavalue":{"value":{"time":"+2015-01-01T00:00:00Z","timezone":0,"before":0,"after":0,"precision":9,"calendarmodel":"http://www.wikidata.org/entity/Q1985727"},"type":"time"},"datatype":"time"},"type":"statement","id":"Q9870$859C62B0-A579-45E3-B838-D79DAB156935","rank":"normal"}],"P102":[{"mainsnak":{"snaktype":"value","property":"P102","datavalue":{"value":"J. Clin. Oncol.","type":"string"},"datatype":"string"},"type":"statement","id":"Q9870$BD9ADAEA-7C4B-4D47-A392-6F9EA005BD00","rank":"normal"}],"P103":[{"mainsnak":{"snaktype":"value","property":"P103","datavalue":{"value":"33","type":"string"},"datatype":"string"},"type":"statement","id":"Q9870$AD818A8C-B9E8-4E07-A174-918AF6F5D55E","rank":"normal"}],"P93":[{"mainsnak":{"snaktype":"value","property":"P93","datavalue":{"value":{"text":"Randomized phase Ib/II study of gemcitabine plus placebo or vismodegib a hedgehog pathway inhibitor in patients with metastatic pancreatic cancer","language":"en"},"type":"monolingualtext"},"datatype":"monolingualtext"},"type":"statement","id":"Q9870$703ECA35-D754-487B-9867-F7D12F3909B9","rank":"normal"}],"P105":[{"mainsnak":{"snaktype":"value","property":"P105","datavalue":{"value":"4284-4292","type":"string"},"datatype":"string"},"type":"statement","id":"Q9870$D401EEFD-CD8F-413A-BFF1-321944C8BD96","rank":"normal"}]},"sitelinks":{"sliswiki":{"site":"sliswiki","title":"Catenacci DV, et al. J. Clin. Oncol. (2015) cited as Ref 607 in DOI: 10.1038/s41392-020-0110-5","badges":[],"url":"https://wikibase.slis.ua.edu/wiki/Catenacci_DV,_et_al._J._Clin._Oncol._(2015)_cited_as_Ref_607_in_DOI:_10.1038/s41392-020-0110-5"}}}}}